R3 Bio, a biotech startup based in Silicon Valley, is pioneering the development of 'headless humans,' or 'organ sacks,' designed to replace traditional animal testing methods. Funded by notable investors such as billionaire Tim Draper and Singapore's Immortal Dragons fund, the company aims to create brainless constructs that contain all human organs except the brain, making them incapable of thought or pain. Co-founder and CEO Alice Gilman stated that the technology has been successfully developed in mice, with plans to extend this to monkeys and eventually human cells. R3 Bio's approach focuses on creating organ-only models to enhance the scalability of testing while adhering to ethical standards. However, the concept has faced skepticism from experts like Jose Cibelli of Michigan State University, who questions the safety of such research, and George Church from Harvard, who finds the idea impractical. Despite these criticisms, proponents argue that these organ systems could lead to advancements in life extension and more ethical research practices.